CoronaryAtlas logo
CoronaryAtlas
creatinine
Pathway / Off-pathway / systemic markers

creatinine

metabolite

Creatinine elevation indicates renal hypoperfusion and glomerular dysfunction secondary to cardiorenal injury and systemic endothelial stress in acute infarction.

Pathway placement
Cascade stepOff-pathway / systemic markers
Confidencehigh
RationaleRenal function marker; renal stress reflects hemodynamic and systemic endothelial injury post-MI.
Druggability
Not assessed (no mapped human gene target).

Type I vs non-Type I discrimination

ScoresIndeterminate
R — rupture / Type-I
—
C — non-Type-I
44
A — assay feasibility
96
E — evidence strength
49
T1DI (composite)
17
Specificity differential (R−C)-29.4
Non-Type-I axis panel
Does this marker also move in each non-Type-I setting? mag 0–3; higher means less Type-I-specific. n/a = no evidence retrieved, which is not the same as no change.
2sepsis / systemic inflammationmag 2
2anemia / acute blood lossn/a
2hypovolemia / dehydrationmag 1
2tachyarrhythmian/a
2hypoxemia / respiratory failuren/a
2hypertensive emergencymag 1
2high-demand / peri-operative stressmag 1
3sudden cardiac deathmag 1
4aPCI-related periproceduralmag 2
4bstent thrombosismag 1
4cin-stent restenosismag 1
5CABG-relatedmag 2
Coverage: 9/12 axes with evidence
Tier: deep-scored (abstract-extracted) · 19 supporting references. See the discrimination table for all markers.

Assay & specimen

Validated clinical assay
Specimen
Serum or plasma; urine
Collection tube
Serum separator (gold/red-top, SST) · Lithium heparin (green-top) · Sterile urine container
Method / principle
Enzymatic (creatininase) or Jaffe (alkaline picrate)
Reagent / substrate
Creatininase→sarcosine oxidase→peroxidase Trinder; or picric acid (Jaffe)
Platform
Automated analyzer
Turnaround · availability
STAT–routine · Universal

Literature evidence(8)